New 2-hour cancer diagnosis and risk assessment - ISRAEL21c

New 2-hour cancer diagnosis and risk assessment - ISRAEL21c

#BenignOrMalignant

New 2-hour cancer diagnosis and risk assessment

Researchers at the Technion-Israel Institute of Technology develop a new method for rapid analysis of a suspicious tumor and its potential to spread.

By Abigail Klein Leichman  AUGUST 17, 2020, 8:03 AM

Abigail Klein Leichman

Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.